Background illustration for clinical trials search

Paid Clinical Trials San Francisco

Discover 2,226 paid clinical trials in San Francisco, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Neonatal White Matter Injury Trial (WRAP)

for
White Matter Injury, Brain Injury, Fetus and Neonate,
Location: San Francisco CA
Sponsor: Bridget LaMonica Ostrem, M.D., Ph.D.

Sex: All

Age: 0

Code: NCT07688746

Phase1, Recruiting
Active & Responsive

Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases

for
Clear Cell Renal Cell Cancer (ccRCC),
Location: San Francisco CA
Sponsor: Kelly Fitzgerald, MD

Sex: All

Age: 18+

Code: NCT07043608

Phase2, Recruiting
Active & Responsive

A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)

for
Urothelial Carcinoma
Location: San Francisco CA, Orange CA, Salt Lake City UT,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT05562830

Phase1, Phase2, Recruiting
Active & Responsive

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

for
Type 1 Diabetes Mellitus
Location: San Francisco CA, Salt Lake City UT, Seattle WA,
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All

Age: 8 - 45

Code: NCT07142252

Phase2, Recruiting
Active & Responsive

Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia

for
AML With Gene Mutations
Location: San Francisco CA, Los Angeles CA, Portland OR,
Sponsor: Lomond Therapeutics Holdings, Inc.

Sex: All

Age: 18+

Code: NCT06366789

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Prehab and Creatine/Whey Supplementation in Frailty Among Patients With Cirrhosis

for
Cirrhosis, Frailty, Sarcopenia
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT07029243

Recruiting
Active & Responsive

PVI Alone Versus PVI Plus PWI and SVCI With PFA

for
Persistent Atrial Fibrillation
Location: San Francisco CA
Sponsor: Edward Gerstenfeld, MD

Sex: All

Age: 18+

Code: NCT07405359

Recruiting
Active & Responsive

A Gaucher Disease Gene Therapy Trial With FLT201

for
Gaucher Disease Type 1
Location: San Francisco CA, Los Angeles CA, Aurora CO, Calgary,
Sponsor: Spur Therapeutics

Sex: All

Age: 18+

Code: NCT07223944

Phase3, Recruiting
Active & Responsive

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

for
Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma,
Location: San Francisco CA, Palo Alto CA, Los Angeles CA,
Sponsor: Nuvation Bio Inc.

Sex: All

Age: 18+

Code: NCT05303519

Phase3, Recruiting
Active & Responsive

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

for
Endometrial Cancer
Location: San Francisco CA, Eugene OR, La Jolla CA, Portland OR,
Sponsor: Faeth Therapeutics

Sex: Female

Age: 18+

Code: NCT06463028

Phase2, Recruiting
Active & Responsive

Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease

for
Chronic Granulomatous Disease (CGD)
Location: San Francisco CA, Sacramento CA, Carson City NV,
Sponsor: Ensoma

Sex: All

Age: 0+

Code: NCT06605378

Recruiting
Active & Responsive

Using Clinical Decision Support to Provide Social Risk-Informed Care for Opioid Use Disorder in the Emergency Department

for
Opioid Use Disorder, Social Determinants of Health (SDOH)
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT06872190

Recruiting
Active & Responsive

A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)

for
PIK3CA-Related Overgrowth Spectrum (PROS),
Location: San Francisco CA, Palo Alto CA, Los Angeles CA,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 2+

Code: NCT06789913

Phase2, Recruiting
Active & Responsive

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

for
Non-small Cell Lung Cancer, Histiocytic Neoplasm, Histiocytosis,
Location: San Francisco CA, Los Angeles CA, Gilbert AZ,
Sponsor: Institut de Recherches Internationales Servier

Sex: All

Age: 18+

Code: NCT05786924

Phase1, Phase2, Recruiting
Active & Responsive

Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing

for
Drug Allergy, Cephalosporin Allergy, Drug Hypersensitivity,
Location: San Francisco CA, Scottsdale AZ, Dallas TX,
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18 - 70

Code: NCT06406114

Phase2, Recruiting
Active & Responsive

Type 1 Diabetes Extension Study

for
Type 1 Diabetes Mellitus, T1DM, T1D
Location: San Francisco CA, Stanford CA, Seattle WA, Aurora CO,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 8 - 35

Code: NCT02734277

Recruiting
Active & Responsive

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

for
Coronavirus Disease (COVID-19)
Location: San Francisco CA, Castroville CA, Carson City NV,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06667700

Phase3, Recruiting
Active & Responsive

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

for
Major Depressive Disorder
Location: San Francisco CA, San Jose CA, Montclair CA,
Sponsor: Syndeio Biosciences, Inc

Sex: All

Age: 18 - 64

Code: NCT07115329

Phase2, Recruiting
Active & Responsive

Oura Blood Pressure Profile Study

for
Hypertension, High Blood Pressure
Location: San Francisco CA
Sponsor: Ouraring Inc.

Sex: All

Age: 22+

Code: NCT07267871

Recruiting
Active & Responsive

PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS

for
Amyotrophic Lateral Sclerosis (ALS)
Location: San Francisco CA, La Jolla CA, Scottsdale AZ,
Sponsor: PhenoNet, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07142291

Phase2, Recruiting